Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor. [electronic resource]
Producer: 20160629Description: 244-256 p. digitalISSN:- 1423-0135
- Animals
- Arteriovenous Shunt, Surgical -- adverse effects
- Becaplermin
- Blood Vessel Prosthesis Implantation -- adverse effects
- Carotid Artery, Common -- surgery
- Cell Cycle Proteins -- metabolism
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Endothelial Cells -- drug effects
- Female
- Graft Occlusion, Vascular -- enzymology
- Humans
- Hyperplasia
- Indoles -- pharmacology
- Jugular Veins -- drug effects
- Myocytes, Smooth Muscle -- drug effects
- Neointima
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-sis -- pharmacology
- Pyrroles -- pharmacology
- Receptors, Platelet-Derived Growth Factor -- antagonists & inhibitors
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Signal Transduction -- drug effects
- Sunitinib
- Sus scrofa
- Time Factors
- Tissue Culture Techniques
- Vascular Endothelial Growth Factor A -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.